Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Post-Mortem MRI and Histopathology in Neurologic Disease: A Translational Approach.

Jonkman LE, Kenkhuis B, Geurts JJG, van de Berg WDJ.

Neurosci Bull. 2019 Apr;35(2):229-243. doi: 10.1007/s12264-019-00342-3. Epub 2019 Feb 21. Review.

PMID:
30790214
2.

Neuropathological and genetic characteristics of a post-mortem series of cases with dementia with Lewy bodies clinically suspected of Creutzfeldt-Jakob's disease.

Geut H, Vergouw LJM, Galis Y, Ingrassia A, de Jong FJ, Quadri M, Bonifati V, Lemstra AW, Rozemuller AJM, van de Berg WDJ.

Parkinsonism Relat Disord. 2019 Feb 13. pii: S1353-8020(19)30057-4. doi: 10.1016/j.parkreldis.2019.02.011. [Epub ahead of print]

PMID:
30777654
3.

Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls.

Jonkman LE, Graaf YG, Bulk M, Kaaij E, Pouwels PJW, Barkhof F, Rozemuller AJM, van der Weerd L, Geurts JJG, van de Berg WDJ.

Neuroimage Clin. 2019 Jan 29;22:101698. doi: 10.1016/j.nicl.2019.101698. [Epub ahead of print]

4.

7T MRI allows detection of disturbed cortical lamination of the medial temporal lobe in patients with Alzheimer's disease.

Kenkhuis B, Jonkman LE, Bulk M, Buijs M, Boon BDC, Bouwman FH, Geurts JJG, van de Berg WDJ, van der Weerd L.

Neuroimage Clin. 2019;21:101665. doi: 10.1016/j.nicl.2019.101665. Epub 2019 Jan 5.

5.

Cerebral Corpora amylacea are dense membranous labyrinths containing structurally preserved cell organelles.

Navarro PP, Genoud C, Castaño-Díez D, Graff-Meyer A, Lewis AJ, de Gier Y, Lauer ME, Britschgi M, Bohrmann B, Frank S, Hench J, Schweighauser G, Rozemuller AJM, van de Berg WDJ, Stahlberg H, Shahmoradian SH.

Sci Rep. 2018 Dec 21;8(1):18046. doi: 10.1038/s41598-018-36223-4.

6.

α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.

van Steenoven I, Majbour NK, Vaikath NN, Berendse HW, van der Flier WM, van de Berg WDJ, Teunissen CE, Lemstra AW, El-Agnaf OMA.

Mov Disord. 2018 Nov;33(11):1724-1733. doi: 10.1002/mds.111. Epub 2018 Nov 15. Erratum in: Mov Disord. 2019 Jan;34(1):159.

PMID:
30440090
7.

Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.

Gündner AL, Duran-Pacheco G, Zimmermann S, Ruf I, Moors T, Baumann K, Jagasia R, van de Berg WDJ, Kremer T.

Neurobiol Dis. 2019 Jan;121:205-213. doi: 10.1016/j.nbd.2018.09.015. Epub 2018 Sep 17.

PMID:
30236861
8.

A comprehensive analysis of SNCA-related genetic risk in sporadic parkinson disease.

Pihlstrøm L, Blauwendraat C, Cappelletti C, Berge-Seidl V, Langmyhr M, Henriksen SP, van de Berg WDJ, Gibbs JR, Cookson MR; International Parkinson Disease Genomics Consortium; North American Brain Expression Consortium, Singleton AB, Nalls MA, Toft M.

Ann Neurol. 2018 Jul;84(1):117-129. doi: 10.1002/ana.25274. Epub 2018 Aug 26.

PMID:
30146727
9.

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.

Moors TE, Paciotti S, Ingrassia A, Quadri M, Breedveld G, Tasegian A, Chiasserini D, Eusebi P, Duran-Pacheco G, Kremer T, Calabresi P, Bonifati V, Parnetti L, Beccari T, van de Berg WDJ.

Mol Neurobiol. 2019 Feb;56(2):1344-1355. doi: 10.1007/s12035-018-1090-0. Epub 2018 Jun 8.

PMID:
29948939
10.

LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study.

Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E, Breedveld GJ, Kuipers D, Minneboo M, Vergouw LJM, Carreras Mascaro A, Yonova-Doing E, Simons E, Zhao T, Di Fonzo AB, Chang HC, Parchi P, Melis M, Correia Guedes L, Criscuolo C, Thomas A, Brouwer RWW, Heijsman D, Ingrassia AMT, Calandra Buonaura G, Rood JP, Capellari S, Rozemuller AJ, Sarchioto M, Fen Chien H, Vanacore N, Olgiati S, Wu-Chou YH, Yeh TH, Boon AJW, Hoogers SE, Ghazvini M, IJpma AS, van IJcken WFJ, Onofrj M, Barone P, Nicholl DJ, Puschmann A, De Mari M, Kievit AJ, Barbosa E, De Michele G, Majoor-Krakauer D, van Swieten JC, de Jong FJ, Ferreira JJ, Cossu G, Lu CS, Meco G, Cortelli P, van de Berg WDJ, Bonifati V; International Parkinsonism Genetics Network.

Lancet Neurol. 2018 Jul;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0. Epub 2018 Jun 7.

PMID:
29887161
11.

Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.

Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, van de Berg WDJ.

Neuropathol Appl Neurobiol. 2018 May 24. doi: 10.1111/nan.12501. [Epub ahead of print]

PMID:
29797340
12.

Loss of Functional Connectivity in Patients with Parkinson Disease and Visual Hallucinations.

Hepp DH, Foncke EMJ, Olde Dubbelink KTE, van de Berg WDJ, Berendse HW, Schoonheim MM.

Radiology. 2017 Dec;285(3):896-903. doi: 10.1148/radiol.2017170438. Epub 2017 Sep 27.

PMID:
28952907
13.

An update on the genetics of dementia with Lewy bodies.

Vergouw LJM, van Steenoven I, van de Berg WDJ, Teunissen CE, van Swieten JC, Bonifati V, Lemstra AW, de Jong FJ.

Parkinsonism Relat Disord. 2017 Oct;43:1-8. doi: 10.1016/j.parkreldis.2017.07.009. Epub 2017 Jul 13. Review.

PMID:
28734699
14.

Origin of α-mannosidase activity in CSF.

Tasegian A, Paciotti S, Ceccarini MR, Codini M, Moors T, Chiasserini D, Albi E, Winchester B, van de Berg WDJ, Parnetti L, Beccari T.

Int J Biochem Cell Biol. 2017 Jun;87:34-37. doi: 10.1016/j.biocel.2017.03.016. Epub 2017 Mar 27.

PMID:
28359775
15.

Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.

Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, van de Berg WD.

Mol Neurodegener. 2017 Jan 25;12(1):11. doi: 10.1186/s13024-017-0154-3. Review.

16.

Nitric Oxide Production in the Striatum and Cerebellum of a Rat Model of Preterm Global Perinatal Asphyxia.

Barkhuizen M, Van de Berg WD, De Vente J, Blanco CE, Gavilanes AW, Steinbusch HW.

Neurotox Res. 2017 Apr;31(3):400-409. doi: 10.1007/s12640-017-9700-6. Epub 2017 Jan 21.

17.

LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.

Dzamko N, Gysbers AM, Bandopadhyay R, Bolliger MF, Uchino A, Zhao Y, Takao M, Wauters S, van de Berg WD, Takahashi-Fujigasaki J, Nichols RJ, Holton JL, Murayama S, Halliday GM.

Mov Disord. 2017 Mar;32(3):423-432. doi: 10.1002/mds.26892. Epub 2016 Dec 2.

PMID:
27911006
18.

Distribution and Load of Amyloid-β Pathology in Parkinson Disease and Dementia with Lewy Bodies.

Hepp DH, Vergoossen DL, Huisman E, Lemstra AW; Netherlands Brain Bank, Berendse HW, Rozemuller AJ, Foncke EM, van de Berg WD.

J Neuropathol Exp Neurol. 2016 Oct;75(10):936-945. Epub 2016 Aug 11.

PMID:
27516115
19.

Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links.

Moors T, Paciotti S, Chiasserini D, Calabresi P, Parnetti L, Beccari T, van de Berg WD.

Mov Disord. 2016 Jun;31(6):791-801. doi: 10.1002/mds.26562. Epub 2016 Feb 29. Review.

PMID:
26923732
20.

Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.

Majbour NK, Vaikath NN, van Dijk KD, Ardah MT, Varghese S, Vesterager LB, Montezinho LP, Poole S, Safieh-Garabedian B, Tokuda T, Teunissen CE, Berendse HW, van de Berg WD, El-Agnaf OM.

Mol Neurodegener. 2016 Jan 19;11:7. doi: 10.1186/s13024-016-0072-9.

21.

Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.

Jongbloed W, van Dijk KD, Mulder SD, van de Berg WD, Blankenstein MA, van der Flier W, Veerhuis R.

J Alzheimers Dis. 2015;46(4):1103-10. doi: 10.3233/JAD-150036.

PMID:
26402636
22.

Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease.

Dijkstra AA, Ingrassia A, de Menezes RX, van Kesteren RE, Rozemuller AJ, Heutink P, van de Berg WD.

PLoS One. 2015 Jun 18;10(6):e0128651. doi: 10.1371/journal.pone.0128651. eCollection 2015.

23.

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.

Vaikath NN, Majbour NK, Paleologou KE, Ardah MT, van Dam E, van de Berg WD, Forrest SL, Parkkinen L, Gai WP, Hattori N, Takanashi M, Lee SJ, Mann DM, Imai Y, Halliday GM, Li JY, El-Agnaf OM.

Neurobiol Dis. 2015 Jul;79:81-99. doi: 10.1016/j.nbd.2015.04.009. Epub 2015 Apr 30.

PMID:
25937088
24.

Topographic mapping between basal forebrain cholinergic neurons and the medial prefrontal cortex in mice.

Bloem B, Schoppink L, Rotaru DC, Faiz A, Hendriks P, Mansvelder HD, van de Berg WD, Wouterlood FG.

J Neurosci. 2014 Dec 3;34(49):16234-46. doi: 10.1523/JNEUROSCI.3011-14.2014.

25.

Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.

Doorn KJ, Moors T, Drukarch B, van de Berg WDj, Lucassen PJ, van Dam AM.

Acta Neuropathol Commun. 2014 Aug 7;2:90. doi: 10.1186/s40478-014-0090-1.

26.

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.

Dijkstra AA, Voorn P, Berendse HW, Groenewegen HJ; Netherlands Brain Bank, Rozemuller AJ, van de Berg WD.

Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952. Epub 2014 Jul 3.

PMID:
24996051
27.

Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.

Hepp DH, Ruiter AM, Galis Y, Voorn P, Rozemuller AJ, Berendse HW, Foncke EM, van de Berg WD.

J Neuropathol Exp Neurol. 2013 Dec;72(12):1162-70. doi: 10.1097/NEN.0000000000000014.

PMID:
24226265
28.

Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients.

Doorn KJ, Goudriaan A, Blits-Huizinga C, Bol JG, Rozemuller AJ, Hoogland PV, Lucassen PJ, Drukarch B, van de Berg WD, van Dam AM.

Brain Pathol. 2014 Mar;24(2):152-65. doi: 10.1111/bpa.12088. Epub 2013 Oct 28.

PMID:
24033473
29.

Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease.

van Dijk KD, Jongbloed W, Heijst JA, Teunissen CE, Groenewegen HJ, Berendse HW, van de Berg WD, Veerhuis R.

Parkinsonism Relat Disord. 2013 Dec;19(12):1079-83. doi: 10.1016/j.parkreldis.2013.07.016. Epub 2013 Aug 6.

PMID:
23932065
30.

Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease.

van Dijk KD, Persichetti E, Chiasserini D, Eusebi P, Beccari T, Calabresi P, Berendse HW, Parnetti L, van de Berg WD.

Mov Disord. 2013 Jun;28(6):747-54. doi: 10.1002/mds.25495. Epub 2013 May 27.

PMID:
23712522
31.

Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients.

Hepp DH, da Hora CC, Koene T, Uitdehaag BM, van den Heuvel OA, Klein M, van de Berg WD, Berendse HW, Foncke EM.

Parkinsonism Relat Disord. 2013 Sep;19(9):795-9. doi: 10.1016/j.parkreldis.2013.04.026. Epub 2013 May 21.

PMID:
23706540
32.

Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.

van Dijk KD, Bidinosti M, Weiss A, Raijmakers P, Berendse HW, van de Berg WD.

Eur J Neurol. 2014 Mar;21(3):388-94. doi: 10.1111/ene.12176. Epub 2013 Apr 30.

PMID:
23631635
33.

Regional differences in gene expression and promoter usage in aged human brains.

Pardo LM, Rizzu P, Francescatto M, Vitezic M, Leday GG, Sanchez JS, Khamis A, Takahashi H, van de Berg WD, Medvedeva YA, van de Wiel MA, Daub CO, Carninci P, Heutink P.

Neurobiol Aging. 2013 Jul;34(7):1825-36. doi: 10.1016/j.neurobiolaging.2013.01.005. Epub 2013 Feb 19.

34.

Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease.

van de Berg WD, Hepp DH, Dijkstra AA, Rozemuller JA, Berendse HW, Foncke E.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S28-30. doi: 10.1016/S1353-8020(11)70011-6. Review.

PMID:
22166446
35.

Imaging hippocampal subregions with in vivo MRI: advances and limitations.

van Strien NM, Widerøe M, van de Berg WD, Uylings HB.

Nat Rev Neurosci. 2011 Dec 20;13(1):70. doi: 10.1038/nrn3085-c1. No abstract available.

PMID:
22183437
36.

The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.

van den Berge SA, van Strien ME, Korecka JA, Dijkstra AA, Sluijs JA, Kooijman L, Eggers R, De Filippis L, Vescovi AL, Verhaagen J, van de Berg WD, Hol EM.

Brain. 2011 Nov;134(Pt 11):3249-63. doi: 10.1093/brain/awr256.

PMID:
22075520
37.

The proteome of the locus ceruleus in Parkinson's disease: relevance to pathogenesis.

van Dijk KD, Berendse HW, Drukarch B, Fratantoni SA, Pham TV, Piersma SR, Huisman E, Brevé JJ, Groenewegen HJ, Jimenez CR, van de Berg WD.

Brain Pathol. 2012 Jul;22(4):485-98. doi: 10.1111/j.1750-3639.2011.00540.x. Epub 2011 Nov 8.

PMID:
21988495
38.

Morphometric changes in the cortical microvascular network in Alzheimer's disease.

Richard E, van Gool WA, Hoozemans JJ, van Haastert ES, Eikelenboom P, Rozemuller AJ, van de Berg WD.

J Alzheimers Dis. 2010;22(3):811-8. doi: 10.3233/JAD-2010-100849.

PMID:
20858968
39.

CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.

Reesink FE, Lemstra AW, van Dijk KD, Berendse HW, van de Berg WD, Klein M, Blankenstein MA, Scheltens P, Verbeek MM, van der Flier WM.

J Alzheimers Dis. 2010;22(1):87-95. doi: 10.3233/JAD-2010-100186.

PMID:
20847452
40.

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, Berendse HW, van de Berg WD.

Neurobiol Dis. 2010 Sep;39(3):229-41. doi: 10.1016/j.nbd.2010.04.020. Epub 2010 May 6. Review.

PMID:
20451609
41.

Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta.

van den Berge SA, Middeldorp J, Zhang CE, Curtis MA, Leonard BW, Mastroeni D, Voorn P, van de Berg WD, Huitinga I, Hol EM.

Aging Cell. 2010 Jun;9(3):313-26. doi: 10.1111/j.1474-9726.2010.00556.x. Epub 2010 Jan 30.

42.

Prenatal stress and neonatal rat brain development.

Van den Hove DL, Steinbusch HW, Scheepens A, Van de Berg WD, Kooiman LA, Boosten BJ, Prickaerts J, Blanco CE.

Neuroscience. 2006;137(1):145-55. Epub 2005 Oct 20.

PMID:
16242847
43.

Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus.

Mulder M, Jansen PJ, Janssen BJ, van de Berg WD, van der Boom H, Havekes LM, de Kloet RE, Ramaekers FC, Blokland A.

Neurobiol Dis. 2004 Jun;16(1):212-9.

PMID:
15207278
44.

A delayed increase in hippocampal proliferation following global asphyxia in the neonatal rat.

Scheepens A, Wassink G, Piersma MJ, Van de Berg WD, Blanco CE.

Brain Res Dev Brain Res. 2003 Apr 14;142(1):67-76.

PMID:
12694945
45.

No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment.

Rutten BP, Wirths O, Van de Berg WD, Lichtenthaler SF, Vehoff J, Steinbusch HW, Korr H, Beyreuther K, Multhaup G, Bayer TA, Schmitz C.

Neurobiol Dis. 2003 Mar;12(2):110-20.

PMID:
12667466
46.

Impact of perinatal asphyxia on the GABAergic and locomotor system.

Van de Berg WD, Kwaijtaal M, de Louw AJ, Lissone NP, Schmitz C, Faull RL, Blokland A, Blanco CE, Steinbusch HW.

Neuroscience. 2003;117(1):83-96.

PMID:
12605895
47.

Perinatal asphyxia induced neuronal loss by apoptosis in the neonatal rat striatum: a combined TUNEL and stereological study.

Van de Berg WD, Schmitz C, Steinbusch HW, Blanco CE.

Exp Neurol. 2002 Mar;174(1):29-36.

PMID:
11869031
48.

Developmental apoptosis in the spinal cord white matter in neonatal rats.

De Louw AJ, Van De Berg WD, De Vente J, Blanco CE, Gavilanes AW, Steinbusch HP, Steinbusch HW, Troost J, Vles JS.

Glia. 2002 Jan;37(1):89-91.

PMID:
11746787
49.

Perinatal asphyxia results in changes in presynaptic bouton number in striatum and cerebral cortex-a stereological and behavioral analysis.

Van de Berg WD, Blokland A, Cuello AC, Schmitz C, Vreuls W, Steinbusch HW, Blanco CE.

J Chem Neuroanat. 2000 Oct;20(1):71-82.

PMID:
11074345
50.

Use of cryostat sections from snap-frozen nervous tissue for combining stereological estimates with histological, cellular, or molecular analyses on adjacent sections.

Schmitz C, Dafotakis M, Heinsen H, Mugrauer K, Niesel A, Popken GJ, Stephan M, Van de Berg WD, von Hörsten S, Korr H.

J Chem Neuroanat. 2000 Oct;20(1):21-9.

PMID:
11074341

Supplemental Content

Loading ...
Support Center